课题基金 / 基金详情

Enhancing immunogenicity of DNA vaccines by targeted delivery to antigen presenting cells.

Enhancing immunogenicity of DNA vaccines by targeted delivery to antigen presenting cells.
通过靶向递送至抗原呈递细胞来增强 DNA 疫苗的免疫原性。
批准号:
LP0883901
负责人:
Prof David Jackson
金额:
$5.5万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Linkage Projects
财政年份:
2008
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2008-07-01 至 2009-12-31

项目摘要

项目成果

Prof David Jackson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Vaccines have proven to be one of the most effective means of preventing infection and also provide promise as a treatment for cancer. However, the range of effective technologies that make possible the delivery of vaccines that can protect against a broad range of infections is limited. DNA based vaccines are attractive because they are relatively easy to produce against a wide range of infections. However, DNA vaccines often provide poor protection against infections. This project will explore a unique technology developed in Australia and that will greatly improve the effectiveness of DNA vaccines against a broad range of diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Harnessing innate immunity to mitigate bovine respiratory disease
  • 批准号:
    DP200102090
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $40.97万
  • 财政年份:
    2020
  • 负责人:
    Prof David Jackson
  • 依托单位:
Enabling Technologies for Design and Delivery of Novel Vaccines Against Infectious Diseases and Cancer.
  • 批准号:
    nhmrc : 1042018
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $61.7万
  • 财政年份:
    2013
  • 负责人:
    Prof David Jackson
  • 依托单位:
Heterosubtypic T cell-inducing vaccines for influenza in humans
  • 批准号:
    nhmrc : 509299
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $23.49万
  • 财政年份:
    2008
  • 负责人:
    Prof David Jackson
  • 依托单位:
Towards pandemic influenza vaccines
  • 批准号:
    nhmrc : 350372
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $24.95万
  • 财政年份:
    2005
  • 负责人:
    Prof David Jackson
  • 依托单位:
海外基金